Sweden may introduce neonatal AAT (alpha1-antitrypsin) screening
This article was originally published in Clinica
Executive Summary
The Swedish government is considering introducing a national neonatal screening programme for alpha1-antitrypsin (AAT) deficiency. This is one of the commonest inherited metabolic disorders, affecting an estimated one in 1,500 babies in Sweden every year.